Nasdaq - Delayed Quote USD

Rydex Biotechnology C (RYCFX)

40.37
-0.38
(-0.93%)
At close: June 13 at 8:02:11 PM EDT
Loading Chart for RYCFX
  • Previous Close 40.75
  • YTD Return -4.97%
  • Expense Ratio 2.40%
  • Category Health
  • Last Cap Gain 50.00
  • Morningstar Rating
  • Morningstar Risk Rating High
  • Sustainability Rating
  • Net Assets 81.31M
  • Beta (5Y Monthly) 0.70
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 51.00%
  • Last Dividend --
  • Inception Date Apr 1, 1998

Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Rydex Funds

Fund Family

Health

Fund Category

81.31M

Net Assets

1998-04-01

Inception Date

Performance Overview: RYCFX

View More

Trailing returns as of 6/6/2025. Category is Health.

YTD Return

RYCFX
4.97%
Category
7.95%
 

1-Year Return

RYCFX
4.64%
Category
30.16%
 

3-Year Return

RYCFX
1.58%
Category
16.10%
 

5-Year Return

RYCFX
0.88%
Category
15.71%
 

People Also Watch

Holdings: RYCFX

View More

Sector Weightings

SectorRYCFX
Healthcare   96.81%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: RYCFX

View More

Research Reports: RYCFX

View More

Top Mutual Funds